Inactive Instrument

Pymepharco Joint Stock Company Stock

Equities

PME

VN000000PME9

Dynamic Chart
Pymepharco Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Pymepharco Joint Stock Company Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Pymepharco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Pymepharco Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2020 CI
Pymepharco Joint Stock Company Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Pymepharco Joint Stock Company Announces Executive Changes CI
Pymepharco Joint Stock Company Announces Earnings Results for the Year 2019; Provides Earnings Guidance for 2020 CI
Pymepharco Joint Stock Company Announces Cash Dividend for 2019, Payable on June 02, 2020 CI
Pymepharco Joint Stock Company Announces Resignation of Mark Burgess Keatley as Member of BOD CI
Pymepharco Joint Stock Company to Set Up a New Branch CI
Pymepharco Joint Stock Company to Pay First Cash Dividend, Payable on March 2020 CI
Pymepharco Joint Stock Company Announces Resignation of Ludwig Otto Friedrich Klöter from Deputy CEO from April 22, 2019 CI
STADA Arzneimittel Aktiengesellschaft (DB:SAZ) acquired an unknown minority stake in Pymepharco Joint Stock Company. CI
Pymepharco Joint Stock Company Announces Second Cash Dividend for 2017, Payable on May 31, 2018 CI
Pymepharco Joint Stock Company Announces Audited Earnings Results for the Year 2017; Provides Earnings Guidance for the Year 2018 CI
More news
Managers TitleAgeSince
Chief Executive Officer 66 89-06-30
Director of Finance/CFO 57 91-06-30
Director/Board Member 53 02-10-31
Members of the board TitleAgeSince
Director/Board Member 46 -
Director/Board Member 56 -
Chief Executive Officer 66 89-06-30
More insiders
Pymepharco Joint Stock Company is a Vietnam-based company primarily engaged in the Pharmaceutical sector. The Company manufactures and distributes pharmaceuticals, medicinal products and materials. Its product line includes antibiotics, analgesics, antipyretics, anti-inflammatory, anti-rheumatic, anti-bacterial combinations, vitamins and minerals. The Company produces medicines in various forms, comprising tablet, soft capsule, hard capsule, granule and liquid.
Sector
-
More about the company